The core activity of inSili.com is to provide innovative technologies and expertise for drug development, particularly in the field of small molecules. This includes: Virtual screening solutions for the identification of active compounds; Molecular design and optimization for the development of new chemical entities; Development of artificial intelligence systems for the discovery of bioactive chemical entities; Provision of software tools such as CopyCATS, ShapeCATS, POOMA, COBRA, and TIGER to support drug development. The company supports the pharmaceutical industry in the discovery and development of new drugs, particularly in the field of small molecules.